Return On Asset ratio Analysis of Inhibikase Therapeutics Inc - Deep Dive
Latest FY ROA
Period Ending - Dec-23
Very Poor ROA
-131.87
Period Ending - Dec-22
Very Poor ROA
-72401.10
Growth
99.82 %
Trailing Twelve Months ROA
Period Ending - Dec-23
Very Poor ROA
-102.17
Most recent Quarter ROA
Period Ending - Mar-24
Very Poor ROA
-42.01
ROA Analysis of Inhibikase Therapeutics Inc
ROA Ratio of Inhibikase Therapeutics Inc with value of -102.17 means poor return on Assets in trailing twelve months. |
ROA Ratio of Inhibikase Therapeutics Inc with value of -42.01 means poor return on Assets in latest Quarter ending on Mar-24. |
ROA Ratio of IKT rose handsomely by 99.82 % this year. |
ROA Ratio with value of -131.87 was highest in Year Dec-23 in last Five Years. |
ROA Ratio with value of -72401.10 was lowest in Year Dec-22 in last Five Years. |
Latest ROA Ratio with value of -131.87 is Greater than Average ROA of -28314.76 in last five years. |
ROA of Inhibikase Therapeutics Inc is negative because of negative Income in last Financial Year , last Quarter and also in last twelve Months. |
Other ROA Related Info of IKT that may interest you.
Inhibikase Therapeutics Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
IKT | 1.84 | 1.81 | 1.66 % | Biotechnology |
Defination of Return On Asset
The return on assets (ROA) is a commonly used profitability ratio that shows how effectively a company uses its assets to generate profit. more ..ROA Related Ratios
ReturnOnEquity | AssetTurnoverRatio |
Tsr Profitability Index
Poor Profitability Stock |
FY - Historical Return On Asset of Inhibikase Therapeutics Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
ROA | -131.87 | -72401.10 | -34815.31 | -19265.03 | -14960.48 | -75.62 | 0 |
Change | 99.82 % | -107.96 % | -80.72 % | -28.77 % | -19684.04 % |
FY Chart of Return On Asset of Inhibikase Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)